252 related articles for article (PubMed ID: 9296084)
1. [Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides].
Vachée A; Scheftel JM; Husson MO; Izard D; Ross P; Monteil H
Pathol Biol (Paris); 1997 May; 45(5):357-62. PubMed ID: 9296084
[TBL] [Abstract][Full Text] [Related]
2. [Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study].
Dubrous P; Cavallo JD; Buisson Y
Pathol Biol (Paris); 1997 Jun; 45(6):472-8. PubMed ID: 9309262
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
Bert F; Briaud I; Branger C; Lambert-Zechovsky N
Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
[TBL] [Abstract][Full Text] [Related]
4. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
Cavallo JD; Leblanc F; Fabre R
Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
[TBL] [Abstract][Full Text] [Related]
5. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
[TBL] [Abstract][Full Text] [Related]
6. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
Croize J; Gout JP; Robert J; Le Noc P
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041
[TBL] [Abstract][Full Text] [Related]
7. [Microbiological study of 386 strains of Pseudomonas aeruginosa isolated in a 30-month span in the Isernia area with special reference to an antimicrobial assay carried out with the ABAC system on 214 of them].
Laurelli T; Ricci N; Ottaviano R; Manuppella AM; Petescia G
Quad Sclavo Diagn; 1985 Dec; 21(4):469-82. PubMed ID: 3939383
[TBL] [Abstract][Full Text] [Related]
8. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
Drissi M; Ahmed ZB; Dehecq B; Bakour R; Plésiat P; Hocquet D
Med Mal Infect; 2008 Apr; 38(4):187-91. PubMed ID: 18395380
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
Cavallo JD; Hocquet D; Plesiat P; Fabre R; Roussel-Delvallez M;
J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
[TBL] [Abstract][Full Text] [Related]
11. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children.
Patzer J; Dzierzanowska D
J Antimicrob Chemother; 1991 Dec; 28(6):869-75. PubMed ID: 1816183
[TBL] [Abstract][Full Text] [Related]
12. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
Ronco E; Vacheron F; Orabona A
Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological studies of the susceptibility of Pseudomonas aeruginosa to antibiotics].
Bert F; Bruneau B; Lambert-Zechovsky N; Branger C
Pathol Biol (Paris); 1994 May; 42(5):491-7. PubMed ID: 7824320
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
Patzer J; Gieburowska R; Dzierzanowska D
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
[TBL] [Abstract][Full Text] [Related]
16. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
[TBL] [Abstract][Full Text] [Related]
17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
18. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
Cluzel M; Chanal M; Sirot J; Cluzel R
Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
Vincent P; Vachée A; Izard D
Pathol Biol (Paris); 1997 Nov; 45(9):771-5. PubMed ID: 9538477
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
